- Trials with a EudraCT protocol (22)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
22 result(s) found for: Voluntary action.
Displaying page 1 of 2.
EudraCT Number: 2005-000408-16 | Sponsor Protocol Number: HS-PM-013 | Start Date*: 2005-04-05 |
Sponsor Name:Karolinska University Hospital, Huddinge | ||
Full Title: Caffeine-mediated modulation of human experimental pain models | ||
Medical condition: Healthy human volunteer subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021879-85 | Sponsor Protocol Number: 10050 | Start Date*: 2010-09-08 |
Sponsor Name:University of Nottingham | ||
Full Title: Mode of action of Moviprep:impact on distribution of intestinal fluid and colonic microbiota | ||
Medical condition: for bowel cleansing prior to any clinical procedure requiring a clean bowel, e.g, bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003903-35 | Sponsor Protocol Number: : NUTH-2005-03384 | Start Date*: 2006-01-19 |
Sponsor Name:Newcastle-upon-Tyne Hospitals NHS Trust | ||
Full Title: : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005402-65 | Sponsor Protocol Number: IIBSP-ANA-2013-163 | Start Date*: 2015-01-19 |
Sponsor Name:Institut de Recerca HSCSP | ||
Full Title: Efficacy and safety of anakinra (antagonist of the interleukin-1 receptor) in the treatment of periarticular inflammation in patients refractory to NSAID and / or steroids | ||
Medical condition: Inflammation in periarticular structures in patients refractory to NSAIDs and / or corticosteroids. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-005895-37 | Sponsor Protocol Number: ASP-MEL-CT001 | Start Date*: 2021-08-03 | |||||||||||
Sponsor Name:Aspire Pharma Limited | |||||||||||||
Full Title: An open label one-treatment, one-period, one-sequence, single oral dose bioavailability study for Melatonin in healthy, adult, human subjects under fasting conditions. | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000250-94 | Sponsor Protocol Number: MAST2 | Start Date*: 2020-07-17 | |||||||||||
Sponsor Name:ISTITUTO AUXOLOGICO ITALIANO | |||||||||||||
Full Title: Mutation-specific therapy for the long QT syndrome | |||||||||||||
Medical condition: Long QT syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000050-23 | Sponsor Protocol Number: 28130 | Start Date*: 2004-09-15 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: Prospective, double-blind, randomized, placebo-controlled dose finding study of the efficacy and safety of 2 target doses of Org 34517 used as adjunctive therapy in subjects with psychotic major de... | |||||||||||||
Medical condition: Psychotic major depression (major depressive episode, severe, with psychotic features) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011911-19 | Sponsor Protocol Number: QUE/09 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Ludwig-Maximilian-University of Munich, Department of Psychiatry | |||||||||||||
Full Title: Impact of quetiapine prolong and escitalopram on the hypothalamic-pituitary-adrenocortical (HPA)-axis activity in depressed patients | |||||||||||||
Medical condition: In this study, patients suffering from unipolar depression are investigated. 40 unipolar depressed inpatients (age 18-65) enter the study after the procedure has been fully explained and written in... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000730-30 | Sponsor Protocol Number: R1788 | Start Date*: 2015-05-21 |
Sponsor Name:Hull and East Yorkshire Hospitals NHS Trust | ||
Full Title: A randomised clinical trial comparing endovenous laser ablation and mechanochemical ablation (ClariVein®) in the management of superficial venous insufficiency. | ||
Medical condition: Varicose veins (VVs) or Superficial Venous Insufficiency (SVI) of the legs results from inflammation mediated damage to vein structure, allowing reverse flow. SVI affects 30% of adults and is assoc... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006773-38 | Sponsor Protocol Number: TSPOC5FOR2022 | Start Date*: 2022-11-29 |
Sponsor Name:Medizinische Einrichtungen des Berzirks Oberpfalz | ||
Full Title: TSPO ligands in the treatment of depression: proof-of-concept of efficacy and underlying mechanisms of action | ||
Medical condition: Unipolar/bipolar depressive disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003773-42 | Sponsor Protocol Number: PM1183-B-005-14 | Start Date*: 2015-03-30 | |||||||||||
Sponsor Name:Pharma Mar S.A. Sociedad Unipersonal | |||||||||||||
Full Title: A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors. | |||||||||||||
Medical condition: Selected Advanced Solid Tumors. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) BE (Completed) SE (Completed) GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002087-12 | Sponsor Protocol Number: BN40703 | Start Date*: 2018-12-07 | ||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | ||||||||||||||||||
Full Title: AN OPEN-LABEL STUDY OF RISDIPLAM IN INFANTS WITH GENETICALLY DIAGNOSED AND PRESYMPTOMATIC SPINAL MUSCULAR ATROPHY | ||||||||||||||||||
Medical condition: Spinal Muscular Atrophy (SMA) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Trial now transitioned) PL (Trial now transitioned) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-003833-25 | Sponsor Protocol Number: EFACLE2008 | Start Date*: 2009-02-05 | |||||||||||||||||||||
Sponsor Name:Universitätskrankenhaus Schleswig-Holstein | |||||||||||||||||||||||
Full Title: Efficacy ans safety of subcutaneous Efalizumab in the treatment of patients with cutaneous lupus erythematosus: A mono-centre, open-label, prospective pilot study | |||||||||||||||||||||||
Medical condition: Cutaneous lupus erythematosus (discoid LE or subacute cutaneous LE) or systemic lupus erythematosus with cutaneous DLE or SCLE lesions without major organ involvment. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000579-40 | Sponsor Protocol Number: D1443L00002 | Start Date*: 2007-10-10 | |||||||||||
Sponsor Name:Charité Universitätsmedizin Berlin | |||||||||||||
Full Title: Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003889-39 | Sponsor Protocol Number: NALPAC | Start Date*: 2021-10-11 |
Sponsor Name:Belgian Group of Digestive Oncology (BGDO) | ||
Full Title: A Non-Comparative Randomized Phase 2 Study, Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for Metastatic Pancreatic Ductal Adenocarcinoma (PDAC), Progressive After Gemcitabine-Abra... | ||
Medical condition: Pancreatic ductal adenocarcinoma (PDAC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001909-14 | Sponsor Protocol Number: APL-B-021-13 | Start Date*: 2016-03-14 | |||||||||||
Sponsor Name:Pharma Mar, S.A. | |||||||||||||
Full Title: A Phase II Study of Plitidepsin in Patients with Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma. | |||||||||||||
Medical condition: Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) CZ (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002366-13 | Sponsor Protocol Number: IB2020-02 | Start Date*: 2021-12-20 | |||||||||||
Sponsor Name:Institut Bergonié | |||||||||||||
Full Title: Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas | |||||||||||||
Medical condition: Advanced /metastatic sarcomas: undifferentiated pleomorphic sarcoma, osteosarcoma and Ewing sarcoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002369-14 | Sponsor Protocol Number: CHUB-Psy-PAThforsAUD | Start Date*: 2023-07-20 | |||||||||||
Sponsor Name:CHU Brugmann | |||||||||||||
Full Title: Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)cognitive Mechanisms. | |||||||||||||
Medical condition: Severe Alcohol Use Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005175-27 | Sponsor Protocol Number: IB2017-01 | Start Date*: 2018-03-14 | ||||||||||||||||||||||||||
Sponsor Name:Institut Bergonié | ||||||||||||||||||||||||||||
Full Title: A phase I/II study of Regorafenib plus Avelumab in digestive tumors | ||||||||||||||||||||||||||||
Medical condition: Adult patients with advanced or metastatic digestive solid tumors | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003303-35 | Sponsor Protocol Number: IB2019-04 | Start Date*: 2021-04-08 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Institut Bergonié | ||||||||||||||||||||||||||||||||||||||
Full Title: Combining epigenetic and immune therapy to beat cancer | ||||||||||||||||||||||||||||||||||||||
Medical condition: | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
